View in EDS

Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: Results from the UNITE study.

Saved in:
Bibliographic Details
Title: Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: Results from the UNITE study.
Authors: Lipton, Richard1 (AUTHOR), Campos, Verena Ramirez2 (AUTHOR), Arie, Zipora Roth-Ben3 (AUTHOR), Krasenbaum, Lynda4 (AUTHOR), Ning, Xiaoping5 (AUTHOR), Galic, Maja6 (AUTHOR), Marmura, Michael7 (AUTHOR)
Source: Journal of the Neurological Sciences. 2023 Supplement, Vol. 455, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:0022510X
DOI:10.1016/j.jns.2023.121112